241 related articles for article (PubMed ID: 16281774)
1. [Better to start from top?].
MMW Fortschr Med; 2005 Oct; 147(42):8. PubMed ID: 16281774
[No Abstract] [Full Text] [Related]
2. [Top-down versus Step-Up: new strategies in the treatment of Crohn's disease].
Meier J; Sturm A
Z Gastroenterol; 2009 Feb; 47(2):240-2. PubMed ID: 19197829
[No Abstract] [Full Text] [Related]
3. [Therapy of chronic inflammatory bowel diseases. TNF-alpha blocker in Crohn disease: earlier use is rewarding].
MMW Fortschr Med; 2008 Dec; 150(51-52):54-5. PubMed ID: 19156959
[No Abstract] [Full Text] [Related]
4. [Maintaining a remission].
Fleig WE;
Z Gastroenterol; 2003 Jan; 41(1):36-42. PubMed ID: 12541172
[No Abstract] [Full Text] [Related]
5. [Chronically active Crohn's disease].
Hoffmann J; Zeitz M;
Z Gastroenterol; 2003 Jan; 41(1):31-5. PubMed ID: 12541171
[No Abstract] [Full Text] [Related]
6. [Drug therapy of Crohn's disease: slowly increase or start aggressively right away?].
Bischoff A
MMW Fortschr Med; 2010 Jan; 152(1-2):20. PubMed ID: 20302159
[No Abstract] [Full Text] [Related]
7. Timing infliximab therapy in pediatric Crohn's disease.
Kirschner BS; Huo D
Gastroenterology; 2007 Mar; 132(3):1167-70. PubMed ID: 17383435
[No Abstract] [Full Text] [Related]
8. [Treatment of Crohn's disease].
Beglinger Ch
Ther Umsch; 2003 Mar; 60(3):159-63. PubMed ID: 12693319
[TBL] [Abstract][Full Text] [Related]
9. [Drug therapy of Crohn disease].
Niemelä S
Duodecim; 2001; 117(8):807-14. PubMed ID: 12116446
[No Abstract] [Full Text] [Related]
10. Combination therapy with infliximab and immunomodulators: is the glass half empty?
Deshpande AR; Abreu MT
Gastroenterology; 2008 Jun; 134(7):2161-3. PubMed ID: 18482585
[No Abstract] [Full Text] [Related]
11. [Current medical treatment of inflammatory bowel disease].
Bosques-Padilla F
Rev Gastroenterol Mex; 2007 Nov; 72 Suppl 2():92-101. PubMed ID: 18277494
[No Abstract] [Full Text] [Related]
12. [Surgery -- fistulas].
Buhr HJ; Kroesen AJ; Stange EF;
Z Gastroenterol; 2003 Jan; 41(1):43-9. PubMed ID: 12541173
[No Abstract] [Full Text] [Related]
13. [Current drug therapy in Crohn disease--national guidelines].
Almer S; Befrits R; Eriksson AS; Halfvarson J; Hindorf U; Löfberg R
Lakartidningen; 2009 Nov 4-12; 106(45):2988-93. PubMed ID: 19998824
[No Abstract] [Full Text] [Related]
14. [CED therapy with infliximab. Rapid and lasting remission - complete mucosal healing].
Wedekind S
MMW Fortschr Med; 2011 Dec; 153(48):54-5. PubMed ID: 22299262
[No Abstract] [Full Text] [Related]
15. Steroid-independent Crohn's disease patients also benefit from combination therapy of infliximab plus azathioprine.
van den Brande JM; Peppelenbosch MP; Hommes DW
Gastroenterology; 2006 Oct; 131(4):1362-3. PubMed ID: 17030216
[No Abstract] [Full Text] [Related]
16. Maintenance infliximab infusions forever?
Lee SD; Surawicz CM
Am J Gastroenterol; 2002 Nov; 97(11):2917-8. PubMed ID: 12425570
[No Abstract] [Full Text] [Related]
17. [For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation].
MMW Fortschr Med; 2009 May; 151(19):38-9. PubMed ID: 19827443
[No Abstract] [Full Text] [Related]
18. Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial.
Lémann M; Mary JY; Duclos B; Veyrac M; Dupas JL; Delchier JC; Laharie D; Moreau J; Cadiot G; Picon L; Bourreille A; Sobahni I; Colombel JF;
Gastroenterology; 2006 Apr; 130(4):1054-61. PubMed ID: 16618399
[TBL] [Abstract][Full Text] [Related]
19. Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.
González Carro P; Pérez Roldán F; Roncero García Escribano O; Lafuente R; Legaz Huidobro ML; Amigo Echenagusía A
J Clin Apher; 2006 Dec; 21(4):249-51. PubMed ID: 16607627
[No Abstract] [Full Text] [Related]
20. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
MMW Fortschr Med; 2005 Apr; 147(17):58-9. PubMed ID: 15903063
[No Abstract] [Full Text] [Related]
[Next] [New Search]